Cisapride Interactions

Coadministration is contraindicated. Itraconazole increases plasma concentrations, potentially increasing pharmacologic effects and adverse reactions.

Source: NLP:itraconazole

Ketoconazole increases cisapride plasma concentrations, potentially causing QT prolongation and life-threatening ventricular tachyarrhythmias including torsades de pointes.

Source: NLP:ketoconazole

Concomitant use is contraindicated due to increased risk of QT prolongation and torsades de pointes.

Source: NLP:levoketoconazole

Weak/moderate CYP3A4/P-gp inhibitor that may increase sirolimus concentrations. Monitor and adjust dosage as needed.

Source: NLP:sirolimus